Basic Information
| LncRNA/CircRNA Name | MIR22HG |
| Synonyms | NA |
| Region | GRCh38_17:1711493-1717174 |
| Ensemble | ENSG00000186594 |
| Refseq | NR_028502 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | Microarray, qPCR |
| Sample | GEO |
| Expression Pattern | down-regulated |
| Function Description | MIR22HG can serve as a ceRNA to modulatemiRNA level. |
| Pubmed ID | 31934786 |
| Year | 2020 |
| Title | Comprehensive Analysis of lncRNAs Associated With the Pathogenesis and Prognosis of Gastric Cancer |
External Links
| Links for MIR22HG | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |